According to PSA, GS and tumor staging [14], PCa patients were stratified into low risk (n = 20), favorable-intermediate (fav-int) risk (n=53), unfavorable-intermediate (un-int) risk (n = 47), and high risk PCa (n = 53). This evidence concerns the gene KLK3 and posterior cortical atrophy.